ABSTRACT We have tested rat liver fructose-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11) and three other gluconeo enic fructose-bisphosphatases as substrates for the catalytic subunit of cyclic AMP-dependent protein kinase. In contrast to the rat liver enzyme, homogeneous preparations of mouse liver, rabbit liver, and pig kidney fructose-hisphosphatase could not be phosphorylatedby the kinase. Comparative sodium dodecyl sulfate/polyacrylamide gel electrophoresis of the four above fructose-bisphosphatases revealed that the subunit molecular weight of the isolated rat liver enzyme (ca. 40,000-42,000) was greater than that of mouse liver, rabbit liver, and pig kidney fructose-bisphosphatases (ca. 36,000-37,000). Treatment of 'P-labeled rat liver fructose-bisphosphatase with trypsin resulted in the conversion of the rat liver enzyme to an active species with a subunit molecular weight identical to that of the three other enzymes, with complete loss ofthe 32P-labeled site. Identical trypsin treatment of pig kidney fructose-bisphosphatase caused no change in the molecular weight of the enzyme. The results suggest that the purified mouse liver, rabbit liver, and pig kidney fructose-bisphosphatases are not substrates for the cyclic AMP-dependent protein kinase in vitro because they lack the phosphorylation-site peptide. This paradoxical result led us to examine in detail other gluconeogenic Fru-P2ases as substrates for the cAMP-dependent protein kinase. This study reports our findings on several FruP2ases and shows that the peptide phosphorylated in the rat liver Fru-P2ase appears to be absent from other isolated Fru-Fru-P2ases.
Fructose-bisphosphatase (Fru-P2ase; D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3.1.3.11) plays an important role in the regulation of gluconeogenesis in mammalian liver and kidney. Several lines of evidence, including those showing increased rates of gluconeogenesis in diabetes (1) , have suggested that the irreversible reaction catalyzed by Fru-P2ase may be under hormonal control (for review, see ref. 2 ). The addition of glucagon or cyclic AMP (cAMP) to the perfused rat liver system or to rat hepatocytes causes an increase in the rates of gluconeogenesis and a decrease in the levels of fructose-bisphosphate (3) (4) (5) . Studies ofsubstrate cycling in isolated rat liver cells also have indicated a site of glucagon action at the fructose-6-phosphate-fructose-1,6-bisphosphate interconversion step (6, 7) .These hormonal effects could be explained by an enhancement of the Fru-P2ase reaction or by a restraint of the opposing glycolytic reaction catalyzed by phosphofructokinase, or both. It has been shown that intravenous administration of glucagon to mice resulted in a stimulation ofFru-P2ase activity and a similar stimulation was observed on administration of cAMP (8) . Because the only documented effects ofcAMP are mediated by protein phosphorylation, it seems reasonable to consider FruP2ase as a substrate for the cAMP-dependent protein kinase.
In 1977, Riou et al. (9) demonstrated that the Fru-P2ase isolated from rat liver could be stoichiometrically phosphorylated in vitro by the catalytic subunit ofthe cAMP-dependent protein kinase. Recently, we confirmed this observation but, in contrast, found that Fru-P2ase isolated from mouse liver could not be phosphorylated by the cAMP-dependent protein kinase (10) .
This paradoxical result led us to examine in detail other gluconeogenic Fru-P2ases as substrates for the cAMP-dependent protein kinase. This study reports our findings on several FruP2ases and shows that the peptide phosphorylated in the rat liver Fru-P2ase appears to be absent from other isolated Fru-Fru-P2ases.
MATERIALS AND METHODS
Fructose-1,6-bisphosphate, AMP, ATP, dithiothreitol, subtilisin Carlsberg, and lactic dehydrogenase (type II from rabbit muscle) were from Sigma. NADP, glucose-6-phosphate dehydrogenase, phosphoglucose isomerase, ovalbumin, and chymotrypsinogen A were from Boehringer Mannheim. Urea, sequanal grade, was from Pierce. Trypsin (TRTPCK) was from Worthington. [y-32P]ATP was from Amersham/Searle or ICN. All other reagents were purchased from common commercial sources and were of the highest purity available.
Rat liver, pig kidney, and mouse liver Fru-P2ases were prepared as described by Riou et al. (9) , Colombo and Marcus (11) , and Marcus and Hosey (10), respectively. Rabbit liver FruP2ase was a gift from S. J. Benkovic of Pennsylvania State University. Fru-P2ase activity was measured as described (12) . Mouse and rabbit liver and pig kidney Fru-P2ases were judged to be homogeneous by NaDodSOjpolyacrylamide gel electrophoresis. In contrast, preparations of rat liver Fru-P2ase sometimes appeared to consist oftwo or three closely migrating bands in the gels. However, the specific activities of all four FruP2ases were similar. This point is directly related to the main theme of this paper and is discussed below.
The catalytic subunit ofcAMP-dependent protein kinase was prepared from bovine liver or heart as described (13) . 32p was incorporated into Fru-P2ases from [y-32P]ATP as described (10) . When indicated, phosphorylated rat liver Fru-P2ase was separated by gel filtration from [y-32P]ATP and the C subunit by using a column (0.6 x 17 cm) of Sephadex G-100 equilibrated in 5 mM potassium malonate/0.2 mM dithiothreitol, pH 6.0.
Polyacrylamide gel electrophoresis in the presence of NaDodSO4 was performed on 9.5 X 14 X 1.5 mm slabs as described (14) . Gels were 10% (wt/vol) in polyacrylamide and were electrophoresed at 30 mA per slab. After completion of electrophoresis, gels were fixed for 1 hr in 40% (vol/vol) isopropanol/10% (vol/vol) acetic acid, stained for 1 hr in 0.1% Coomassie brilliant blue R/25% isopropanol/10% acetic acid and destained in 10% isopropanol/10% acetic acid. The gels were dried under vacuum on a Hoefer slab gel dryer, and radioautograms were prepared using Kodak no-screen x-ray film. The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
RESULTS AND DISCUSSION
The results ofexperiments designed to examine rat, mouse, and rabbit liver Fru-P2ases and pig kidney Fru-P2ase as substrates for the catalytic subunit ofthe cAMP-dependent protein kinase showed that only the purified rat liver enzyme was a substrate for the phosphorylation reaction ( Fig. 1) . Whereas the rat liver enzyme incorporated approximately 1 mol of Pi per mol of enzyme protomer, the three other enzymes tested incorporated less than 0.1 mol of Pi per mol. We have made numerous attempts to phosphorylate the pig kidney and mouse liver FruP2ases under a wide variety ofconditions. We have reported the negative results obtained with the mouse liver Fru-P2ase (10) . Experiments with the pig kidney Fru-P2ase included varying Fru-P2ase from 3.2 to 144 ,uM; varying the C subunit from 0.2 to 20 ,uM; adding singly in individual experiments 2.5 mM fructose-1,6-bisphosphate, 10 mM KF, 0.2 mM Ca2+, 0.2 mM Zn2", 0.2 mM Mn2+, or 0.2 mM AMP; varying the pH from 6.0 to 8.3; incubating at 37C instead of 300C; and utilizing FruP2ase after subtilisin digestion. In all cases the results were as shown in Fig. 1 . We have determined (10) that pig kidney and mouse liver Fru-P2ases contained no endogenous phosphate, ruling out the possibility that the enzymes are phosphorylated as isolated.
That only rat liver Fru-P2ase of the four enzymes we tested can be phosphorylated in vitro suggests several possible interpretations. Rat liver Fru-P2ase might have a unique conformation in which a phosphorylatable site is exposed in this enzyme but "buried" in other Fru-P2ases. Alternatively, rat liver FruP2ase might contain a phosphorylatable site that is absent in other Fru-P2ases. We have explored both possibilities.
In order to act as a substrate for the cAMP-dependent protein kinase, a protein must contain a certain local amino acid sequence that is recognized by the kinase (15) . However, it is known that some proteins contain sites for phosphorylation that become accessible only as the proteins are unfolded or denatured (16) . Therefore, we determined whether the four FruP2ases contained sites that could be phosphorylated by the C subunit after the Fru-P2ases were unfolded in 8 M urea. In each case, the Fru-P2ase in 8 M urea was added to the phosphoryla- (Fig. 2) . In contrast, the pig kidney Fru-P2ase, which was inactive under these conditions, became a good substrate for the kinase. However, as will be reported elsewhere, we have determined the amino acid sequence of the site phosphorylated in unfolded pig kidney FruP2ase and found it to be completely different from that reported by others (17, 18) to be the site phosphorylated in rat liver FruP2ase. The sequence data and the fact that the mouse and rabbit liver Fru-P2ases did not become substrates after unfolding rule out the possibility that a phosphorylation site similar to that found in rat liver Fru-P2ases is "buried" in other Fru-P2ases.
Therefore, we performed experiments to determine if the phosphorylation site is missing in the nonphosphorylatable FruP2ases. Pilkis et al. have reported that trypsin removes the phosphorylation site from rat liver Fru-P2ase (17) . Furthermore, these workers as well as Humble et al. (18) have isolated and partially determined the sequence of the peptide containing the phosphorylation site in rat liver Fru-P2ase.
We characterized the effect of trypsin on pig kidney FruP2ase and 32P-labeled rat liver Fru-P2ase using NaDodSO4/ polyacrylamide gel electrophoresis and radioautography (Fig.  3) . As shown by the 0 time controls (Fig. 3A) , the molecular weight of "native" rat liver Fru-P2ase (ca. 40,000-42,000) is greater than that of the pig kidney Fru-P2ase (ca. 36,500). This difference in molecular weight also was observed when the electrophoresis was performed by another method (19) . The time course of trypsin treatment shows that trypsin has no noticeable effect on the molecular weight of the pig kidney FruP2ase. However, with time, trypsin cleaves a small peptide from the larger Mr 40,000-42,000 rat liver Fru-P2ase subunit, converting it to a form identical in molecular weight to the trypsininsensitive pig kidney Fru-P2ase. Fig. 3B represents a radioautogram ofthe gel from Fig. 3A and shows the effectoftrypsin on the 32P-label in rat liver Fru-P2ase. Trypsin treatment completely removes the 32P-label from the rat liver Fru-P2ase, indicating that the phosphorylation site is contained in a small peptide and that the final Mr 36,500 trypsin product lacks the Proc. Natl. Acad. 32P-labeled rat liver Fru-P2ase was incubated for 40 min with trypsin as described in Fig. 3 and then was applied to a column ofSephadex G-100 (0.6 x 18 cm) equilibrated with 5 mM malonate, pH 6.0/0.2 mM dithiothreitol. Fractions (0.5 ml) were collected and analyzed for Fru-P2ase activity (.) and radioactivity (0).
FIG. 3.
Effect of trypsin on 32P-labeled rat liver Fru-P2ase and pig kidney Fru-P2ase as visualized by NaDodSO4/polyacrylamide gel electrophoresis and radioautography. Rat liver Fru-P2ase was phosphorylated under the conditions described in Fig. 1 phosphorylation site. A small decrease (15-20%) in rat liver FruP2ase activity at pH 7.3 was associated with the loss ofthe phosphopeptide and conversion to the Mr 36,500 form (data not shown), but the significance ofthis minor change is not known. As discussed and noted in Fig. 3A , preparations ofrat liver FruP2ase sometimes appeared to consist ofseveral closely migrating bands in NaDodSO4 gels. We believe these bands represent a mixture of enzyme forms of Fru-P2ase containing perhaps the native enzyme and products oflimited proteolytic digestion (see below for further discussion). It should be noted that a subunit of Mr 35,000-36,500 has been reported consistently (20) for neutral pH-optimum mammalian Fru-P2ases, with the exception of the rat liver Fru-P2ase. A number of different subunit molecular weights for the rat liver Fru-P2ase ranging from 36,000 to 45,000 are present in the literature (9, (21) (22) (23) (24) Sephadex G-100 gel filtration of 32P-labeled rat liver Fru-P2ase previously treated with trypsin showed that Fru-P2ase activity was eluted in the front of the column and was clearly resolved from the radioactive peak; no radioactivity was coeluted with enzyme activity (Fig. 4) . These results indicate that the peptide containing the phosphorylation site is easily separable from the remainder of the catalytically active Fru-P2ase and that the two probably do not remain associated after proteolysis.
Others have stated that the phosphorylation site in rat liver Fru-P2ase is not localized in the NH2-terminal peptide removed by subtilisin (17, 18) . We also examined the effect of subtilisin on phosphorylated rat liver Fru-P2ase and found that the radioactivity in rat liver Fru-P2ase remains quantitatively associated with the larger subtilisin COOH-terminal products (data not shown). In direct contrast, trypsin removed the phosphorylation site into a small peptide (17) (Fig. 3 and 4) . In view of the opposing effects of these two proteases and the well-established effect of subtilisin on the NH2 terminus ofthe Fru-P2ase, the data demonstrate that the site of trypsin cleavage and the phosphorylation site of rat liver Fru-P2ase are located close to the COOH terminus of the enzyme. This is similar to other enzymes such as glycogen synthetase (25) The data suggested that the inability to phosphorylate other Fru-P2ases may be due to the absence of the COOH-terminal phosphorylatable peptide in these enzymes. Using NaDodSO4/ polyacrylamide gel electrophoresis, we compared the subunit molecular weights of several Fru-P2ases to that of rat liver FruP2ase before and after trypsin treatment. Native rat liver FruP2ase was larger than mouse liver, rabbit liver, and pig kidney Fru-P2ases (Fig. 5) . However, trypsin-treated rat liver FruP2ase, which lost the phosphorylation site, was identical in molecular weight to the three other The data demonstrate that the rat liver Fru-P2ase is phosphorylated in a trypsin-sensitive peptide located in the COOHterminal region of the enzyme. In addition, the data strongly suggest that the mouse and rabbit liver and pig kidney Fru Fig. 3 ; a, rat liver Fru-P2ase (3.6 jig); b, pig kidney Fru-P2ase One likely possibility and one that is amenable to testing is that the trypsin-sensitive phosphorylatable peptide is removed from the nonphosphorylatable Fru-P2ases by endogenous proteases during the enzyme isolation procedures. A second explanation for the differences between rat liver and the other Fru-P2ases is that proteolysis of Fru-P2ase near the COOH terminus may be a normal post-translational modification of the enzyme that for some unknown reason does not occur in rat liver. A third possibility is that rat liver Fru-P2ase is synthesized as a larger enzyme than other Fru-P2ases. The present data do not allow us to discriminate among these possibilities. However, if glucagon activates Fru-P2ases in vivo through a cAMP-dependent phosphorylation process, the phosphorylation site presumably is lost from at least several of these enzymes during enzyme isolation procedures. Otherwise, phosphorylation of Fru-P2ase by the cAMP-dependent protein kinase would not appear to be a general property ofgluconeogenic Fru-P2ases.
